Interdisciplinary Rheumatology: Rheumatology and Ophthalmology

1. Auflage 2025
ISBN: 978-1-032-59231-2
Verlag: Taylor & Francis Ltd

Buch, Englisch, 238 Seiten, Format (B × H): 178 mm x 254 mm

Reihe: Interdisciplinary Rheumatology

Ask rheumatologists what one thing that they most desire is and they will say: I wish I knew more about ophthalmology so I could care for patients whose rheumatologic diseases manifest with ophthalmic complications. Ophthalmologists feel just the same, seeking to understand the implications that autoimmune diseases have for their patients. As part of the Interdisciplinary Rheumatology book series, this book is a dialogue between rheumatologists and ophthalmologists providing a masterclass from world-renowned experts. Led by a team of international editors with in-depth knowledge and cutting-edge research on topics like vasculitis and systemic lupus erythematous, among others.

Key Features:

1. Provides a clinical approach to the patient with ophthalmic manifestations of rheumatic disease.
2. Details cutting-edge research with inputs from the world’s leading experts, for both ophthalmologists and rheumatologists.
3. Discusses possible future directions for research and advancement.

Zielgruppe

Postgraduate, Professional Practice & Development, Professional Reference, and Professional Training

Autoren/Hrsg.

Valeriano-Marcet, Joanne

Kopplin, Laura

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Augenheilkunde, Optometrie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Rheumatologie, Muskelerkrankungen

Inhaltsverzeichnis

1. General overview of the eye in health and in autoimmune disease 2. Approach to the Patient with Ophthalmologic Manifestations of Rheumatic 3. Ocular Manifestations of Rheumatoid Arthritis 4. Ophthalmologic Disease in the ANCA Associated Vasculitides 5. Ophthalmologic Disease in Giant Cell Arteritis, Takayasu arteritis, and other systemic non-ANCA Vasculitides 6. Ophthalmologic Diseases in the Spondyloarthritides 7. Ophthalmic Disease in Sarcoidosis 8. Ophthalmologic Disease in Systemic Lupus Erythematosus and Antiphospholipid Syndrome 9. Ophthalmologic Disease in Behcet Syndrome 10. Ophthalmologic Involvement in Sjögren’s Disease 11. Ophthalmologic Disease in IgG4-Related Disease 12. Ophthalmologic Disease in Cogan Syndrome, Relapsing Polychondritis, VEXAS Syndrome and other disorders 13. Ophthalmologic Disease in Systemic Sclerosis, Polymyositis and Dermatomyositis 14. Inflammatory Ocular Syndromes Without Systemic Associations 15. Considerations for Pediatric Rheumatologic Patients with Ophthalmic Disease 16. Ophthalmologic Side Effects of Rheumatologic Medications 17. Immunosuppressive Therapies for Inflammatory Ocular Disease

Über Autor(innen)

Dr. Laura Kopplin is an Assistant Professor in Ophthalmology at the University of Wisconsin School of Medicine and Public Health. She completed a fellowship in Uveitis and Ocular Immunology at the Casey Eye Institute--Oregon Health & Science University in Portland, Oregon. Her research interests include epidemiology and risk factors for inflammatory eye diseases, clinical trials of uveitis therapeutics, biomarkers for uveitis outcomes, and clinical management of the ocular inflammatory disease. She is also the co-host of the podcast Headlight in the Fog: The Uveitis Podcast.

Dr. Joanne Valeriano-Marcet is a Professor of Medicine and Fellowship Program Director at the University of South Florida in Tampa, FL. She completed her fellowship in rheumatology at Mount Sinai Medical Center. Her awards have included the Parker J. Palmer “Courage to Teach” Award for Program Director Excellence from the ACGME, the Outstanding GME Program Director Award from USF, and she has been named among the Best Doctors in America. She has published widely and served on the ACGME Working Group to develop the Rheumatology Milestones 2.0.